Literature DB >> 12944902

Akt negatively regulates translation of the ternary complex factor Elk-1.

Claudia Figueroa1, Anne B Vojtek.   

Abstract

Cross-talk between signaling pathways plays an important role in regulation of cell growth, differentiation, survival, and death. Here, we show that Akt regulates the Elk-1 transcription factor, independent of its negative regulation of Raf kinases. Using a constitutively active Mek1 to bypass the regulation of Raf by Akt, we find that the Elk-1 and Sap1a proteins are dramatically decreased in the presence of activated Akt. Akt catalytic activity is required. Also, Mek-dependent activation of a TCF (Elk-1/Sap-1a)-dependent c-fos reporter is decreased by activated Akt. Neither the level of Elk-1 mRNA nor the stability of the Elk-1 protein is altered by activated Akt. Instead, the rate of incorporation of labeled methionine into Elk-1 protein is decreased in the presence of Akt. In addition, the level of the Elk-1 protein but not GFP is significantly decreased in the presence of activated Akt, when GFP is expressed from an IRES element in a bicistronic message with Elk-1. We conclude that Akt negatively regulates translation of the Elk-1 mRNA. A coding region determinant that maps within the first 279 nts of the Elk-1 message is necessary and sufficient for Akt-mediated regulation of Elk-1.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12944902     DOI: 10.1038/sj.onc.1206496

Source DB:  PubMed          Journal:  Oncogene        ISSN: 0950-9232            Impact factor:   9.867


  8 in total

1.  Akt down-regulates ERK1/2 nuclear localization and angiotensin II-induced cell proliferation through PEA-15.

Authors:  Marianne Gervais; Céline Dugourd; Laurent Muller; Corinne Ardidie; Brigitte Canton; Laetitia Loviconi; Pierre Corvol; Hervé Chneiweiss; Catherine Monnot
Journal:  Mol Biol Cell       Date:  2006-07-05       Impact factor: 4.138

2.  Elk-1 regulates retinal ganglion cell axon regeneration after injury.

Authors:  Takahiko Noro; Sahil H Shah; Yuqin Yin; Riki Kawaguchi; Satoshi Yokota; Kun-Che Chang; Ankush Madaan; Catalina Sun; Giovanni Coppola; Daniel Geschwind; Larry I Benowitz; Jeffrey L Goldberg
Journal:  Sci Rep       Date:  2022-10-19       Impact factor: 4.996

3.  Akt inhibitor a-443654 interferes with mitotic progression by regulating aurora a kinase expression.

Authors:  Xuesong Liu; Yan Shi; Keith W Woods; Paul Hessler; Paul Kroeger; Julie Wilsbacher; Jieyi Wang; Jean Y Wang; Chunying Li; Qun Li; Saul H Rosenberg; Vincent L Giranda; Yan Luo
Journal:  Neoplasia       Date:  2008-08       Impact factor: 5.715

4.  The translational response of the human mdm2 gene in HEK293T cells exposed to rapamycin: a role for the 5'-UTRs.

Authors:  Raphael Genolet; Gwendoline Rahim; Pascale Gubler-Jaquier; Joseph Curran
Journal:  Nucleic Acids Res       Date:  2010-09-28       Impact factor: 16.971

5.  Alternatively spliced isoforms of the human elk-1 mRNA within the 5' UTR: implications for ELK-1 expression.

Authors:  Tanguy Araud; Raphael Genolet; Pascale Jaquier-Gubler; Joseph Curran
Journal:  Nucleic Acids Res       Date:  2007-06-25       Impact factor: 16.971

Review 6.  Current Practice in Bicistronic IRES Reporter Use: A Systematic Review.

Authors:  Guus Gijsbertus Hubert van den Akker; Federico Zacchini; Bas Adrianus Catharina Housmans; Laura van der Vloet; Marjolein Maria Johanna Caron; Lorenzo Montanaro; Tim Johannes Maria Welting
Journal:  Int J Mol Sci       Date:  2021-05-14       Impact factor: 5.923

7.  Database for mRNA half-life of 19 977 genes obtained by DNA microarray analysis of pluripotent and differentiating mouse embryonic stem cells.

Authors:  Lioudmila V Sharova; Alexei A Sharov; Timur Nedorezov; Yulan Piao; Nabeebi Shaik; Minoru S H Ko
Journal:  DNA Res       Date:  2008-11-11       Impact factor: 4.458

8.  An AUG codon conserved for protein function rather than translational initiation: the story of the protein sElk1.

Authors:  Noemie Legrand; Tanguy Araud; Beatrice Conne; Odin Kuijpers; Pascale Jaquier-Gubler; Joseph Curran
Journal:  PLoS One       Date:  2014-07-18       Impact factor: 3.240

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.